Author: Kleinman, Steve; Stassinopoulos, Adonis
Title: Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation Document date: 2015_8_25
ID: qlddzgbg_21
Snippet: It is important for PI clinical trial protocols to include an assessment of RBC alloimmunization rates. Since the overall RBC alloimmunization rate is low in the general transfused population, 83 it is unlikely that pivotal clinical trials will be powered to adequately evaluate this phenomenon and data from routine use will be required......
Document: It is important for PI clinical trial protocols to include an assessment of RBC alloimmunization rates. Since the overall RBC alloimmunization rate is low in the general transfused population, 83 it is unlikely that pivotal clinical trials will be powered to adequately evaluate this phenomenon and data from routine use will be required.
Search related documents:
Co phrase search for related documents- clinical trial and pivotal clinical trial: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date